
|Articles|September 27, 2007
DEA: Marijuana-related generic drugs belong under Schedule III
Generic versions of Marinol should be classified as Schedule III when they are approved, according to the Drug Enforcement Administration
Advertisement
Because generic versions of Marinol (dronabinol, Solvay Pharmaceuticals) are in development, DEA is proposing to put these upcoming products that contain tetrahydrocannabinols (THC), when approved, under the same classification of Schedule III. THC is believed to be the major psychoactive component of the cannabis (marijuana) plant. This DEA proposal was published in the Sept. 24
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Addressing Depression Symptoms Can Significantly Improve Asthma Outcomes
2
President Trump Signs Sweeping, Unprecedented Federal PBM Reform
3
What the Newest Landmark PBM Reform Means for the Pharmacy Industry
4
TrumpRx Officially Launches, Introduces Drug Prices
5























